Thyroid and the Heart

Overview

Journal Am J Med

Specialty General Medicine

Date 2014 Mar 26

PMID 24662620

Citations 97

Authors

Ira Martin Grais

James R Sowers

Affiliations

Soon will be listed here.

Abstract

Thyroid hormones modulate every component of the cardiovascular system necessary for normal cardiovascular development and function. When cardiovascular disease is present, thyroid function tests are characteristically indicated to determine if overt thyroid disorders or even subclinical dysfunction exists. As hypothyroidism, hypertension, and cardiovascular disease all increase with advancing age, monitoring of thyroid-stimulating hormone, the most sensitive test for hypothyroidism, is important in this expanding segment of our population. A better understanding of the impact of thyroid hormonal status on cardiovascular physiology will enable health care providers to make decisions about thyroid hormone evaluation and therapy in concert with evaluating and treating hypertension and cardiovascular disease. The goal of this review is to access contemporary understanding of the effects of thyroid hormones on normal cardiovascular function and the potential role of overt and subclinical hypothyroidism and hyperthyroidism in a variety of cardiovascular diseases.

Citing Articles

Unresolved Complete Heart Block in a Patient Treated for Euthyroid Graves' Disease: A Diagnostic Dilemma.

Natesan T, Murshed M, Abraham S, Fernandez C Cureus. 2025; 16(12):e75746.

PMID: 39811201 PMC: 11731699. DOI: 10.7759/cureus.75746.

A Network and Pathway Analysis of Genes Associated With Atrial Fibrillation.

Zeng M, Yang X, Chen Y, Fan J, Cao L, Wang M Cardiovasc Ther. 2025; 2024:7054039.

PMID: 39742001 PMC: 11470814. DOI: 10.1155/2024/7054039.

Prognostic significance of free triiodothyronine levels in alpine region patients undergoing drug-coated balloon therapy for coronary heart disease.

Zhang Q, Wu G, Wang Z, Cui Z, Zhang H J Cardiothorac Surg. 2024; 19(1):656.

PMID: 39702216 PMC: 11660787. DOI: 10.1186/s13019-024-03174-z.

The Association Between Elevated Thyroid-Stimulating Hormone Levels and Prolonged Length of Stay Among Adult Diabetic Patients Hospitalized in Internal Medicine Departments: A Large Historical Cohort Study.

Kuchar A, Ziv-Baran T, Feigin E, Shemesh E, Buch A, Eldor R J Clin Med. 2024; 13(22).

PMID: 39597981 PMC: 11594665. DOI: 10.3390/jcm13226837.

Clinical associations with thyroid disease in ANCA-associated vasculitis.

Zhang Z, Huang W, Ren F, Luo L, Zhou J, Huang D Clin Rheumatol. 2024; 43(12):3821-3827.

PMID: 39441466 DOI: 10.1007/s10067-024-07146-5.

References

Hak A, Pols H, Visser T, Drexhage H, Hofman A, Witteman J . Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000; 132(4):270-8. DOI: 10.7326/0003-4819-132-4-200002150-00004. View

McKee A, Peyerl F . TSI assay utilization: impact on costs of Graves' hyperthyroidism diagnosis. Am J Manag Care. 2012; 18(1):e1-14. View

Cooper D, Biondi B . Subclinical thyroid disease. Lancet. 2012; 379(9821):1142-54. DOI: 10.1016/S0140-6736(11)60276-6. View

Kenessey A, Ojamaa K . Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem. 2006; 281(30):20666-20672. DOI: 10.1074/jbc.M512671200. View

Volzke H, Alte D, Dorr M, Wallaschofski H, John U, Felix S . The association between subclinical hyperthyroidism and blood pressure in a population-based study. J Hypertens. 2006; 24(10):1947-53. DOI: 10.1097/01.hjh.0000244942.57417.8e. View

Dayan C, Daniels G . Chronic autoimmune thyroiditis. N Engl J Med. 1996; 335(2):99-107. DOI: 10.1056/NEJM199607113350206. View

Gerdes A, Iervasi G . Thyroid replacement therapy and heart failure. Circulation. 2010; 122(4):385-93. DOI: 10.1161/CIRCULATIONAHA.109.917922. View

Fazio S, Palmieri E, Lombardi G, Biondi B . Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res. 2004; 59:31-50. DOI: 10.1210/rp.59.1.31. View

Mangiardi L, Gaita F, Brun S, Presbitero P, Nademanee K, Singh B . Atrioventricular block complicating amiodarone-induced hypothyroidism in a patient with pre-excitation and rate-dependent bilateral bundle branch block. J Am Coll Cardiol. 1986; 7(1):180-4. DOI: 10.1016/s0735-1097(86)80279-0. View

10.

Niafar M, Toufan M, Ghafoori S, Aghamohammadzadeh N . Subclinical hypothyroidism effects on cardiac function. Pak J Biol Sci. 2009; 12(15):1056-62. DOI: 10.3923/pjbs.2009.1056.1062. View

11.

January C, Estes 3rd N, Page R, Ezekowitz M, Slotwiner D, Jackman W . 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010; 57(2):223-42. DOI: 10.1016/j.jacc.2010.10.001. View

12.

Alexander J . A PERICARDIAL EFFUSION OF "GOLD-PAINT" APPEARANCE DUE TO THE PRESENCE OF CHOLESTERIN. Br Med J. 2010; 2(3067):463. PMC: 2343352. DOI: 10.1136/bmj.2.3067.463. View

13.

Klein I, Danzi S . Thyroid disease and the heart. Circulation. 2007; 116(15):1725-35. DOI: 10.1161/CIRCULATIONAHA.106.678326. View

14.

Razvi S, Weaver J, Butler T, Pearce S . Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med. 2012; 172(10):811-7. DOI: 10.1001/archinternmed.2012.1159. View

15.

Traube E, Coplan N . Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature. Tex Heart Inst J. 2011; 38(3):225-8. PMC: 3113146. View

16.

Petersen P, Hansen J . Stroke in thyrotoxicosis with atrial fibrillation. Stroke. 1988; 19(1):15-8. DOI: 10.1161/01.str.19.1.15. View

17.

Zullo M, Devereux R, Lutas E, Brown W . Mitral valve prolapse and hyperthyroidism: effect of patient selection. Am Heart J. 1985; 110(5):977-80. DOI: 10.1016/0002-8703(85)90195-4. View

18.

Savinova O, Liu Y, Aasen G, Mao K, Weltman N, Nedich B . Thyroid hormone promotes remodeling of coronary resistance vessels. PLoS One. 2011; 6(9):e25054. PMC: 3178602. DOI: 10.1371/journal.pone.0025054. View

19.

Chang H . THE BLOOD VOLUME IN HYPERTHYROIDISM. J Clin Invest. 1931; 10(3):475-87. PMC: 435764. DOI: 10.1172/JCI100365. View

20.

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F . New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol. 2012; 59(16):1413-25. DOI: 10.1016/j.jacc.2012.02.008. View